[Treatment of hepatitis E virus infection]

Presse Med. 2015 Mar;44(3):339-42. doi: 10.1016/j.lpm.2014.10.011. Epub 2015 Jan 29.
[Article in French]


The reduction of immunosuppressive therapy is the first-line therapeutic option in transplant-patients with chronic hepatitis E virus infection. Pegylated-interferon has been used for treating hepatitis E virus infection. Ribavirin alone is the treatment of choice of hepatitis E virus infection. Ribavirin is efficient for treating chronic hepatitis E in transplant patients, HIV patients, and hematology patients receiving or not chemotherapy. Ribavirin should be given to patients presenting hepatitis E virus associated extra-hepatic manifestations. The place of ribavirin therapy at acute phase is yet to be determined.

Publication types

  • English Abstract
  • Review

MeSH terms

  • Acute-Phase Reaction / therapy
  • Chronic Disease
  • HIV Infections / complications
  • HIV Infections / therapy
  • HIV-1
  • Hepatitis E / complications
  • Hepatitis E / therapy*
  • Hepatitis E virus*
  • Humans
  • Organ Transplantation